Skip to main content

Recent Transactions

MC Diagnostics

Sale of MC Diagnostics to ACT Genomics

Deal Type: Sale

Deal Size: Not Disclosed

Seneca Corporate Finance acted as lead advisor to the shareholders of MC Diagnostics on the sale to international firm, ACT Genomics.

ACT Genomics is entering the European precision medicine market with the acquisition of MCD which specialises in the design and development of molecular diagnostics across the fields of immunogenetics, immunology, blood banking and microbiology.

The companies have partnered to develop fusion genechips on MCD’s ALDAS platform, from which tests can now be performed at the point of care.

Contact Us

Online form

Please contact us to discuss any Corporate Finance needs with one of our team.
  • Hidden
  • Would you like to receive Seneca Partners Newsletter updates?

  • Would you like to receive Seneca Partners Onside Magazine?

  • Would you like to receive Seneca Partners Event Updates?

  • Would you like to receive Seneca Partners Event Updates?

  • This field is for validation purposes and should be left unchanged.

Or via phone or email on